Clinical Trial Update: Safety and Efficacy of "Immuncell-LC" in TACE Therapy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluated the safety and efficacy of Immuncell-LC as an adjunct in transarterial chemoembolization for hepatocellular carcinoma, with c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Immuncell-LC

Snippet

Sponsor: GC Cell Corporation | Conditions: Carcinoma, Hepatocellular | Phase 2 | Status: COMPLETED